2024-11-22 - Analysis Report
## Colgate-Palmolive Co (CL) Stock Analysis Report

**1. Performance vs. S&P 500 (VOO):**

Colgate-Palmolive Co (CL) is a multinational consumer goods company that manufactures and markets oral hygiene, personal care, home care, and pet nutrition products.  The cumulative return for CL is 46.64%, significantly lagging behind the S&P 500 (VOO) cumulative return of 126.85%. This represents a difference of -80.21%, placing it at the 6.74th percentile of its historical performance relative to the S&P 500 based on the provided data.  The provided alpha and beta values suggest that CL has underperformed the market (beta < 1) and generated below-market alpha in most periods.


**2. Recent Price Movement:**

* **Closing Price:** $94.25
* **5-day Moving Average:** $93.99
* **20-day Moving Average:** $93.26
* **60-day Moving Average:** $99.49

The price is currently below all three moving averages, suggesting a potential downward trend.  The significant difference between the current price and the 60-day moving average indicates a considerable price drop in the past two months.


**3. Technical Indicators and Expected Return:**

* **RSI:** 53.28 (Slightly above neutral; neither overbought nor oversold)
* **PPO:** 0.53 (Positive, suggesting bullish momentum)
* **20-Day Relative Divergence:** -8.42 (Negative, indicating recent short-term downward price movement)
* **Expected Return:** 0.0% (The provided expected return is 0%, implying no significant expected outperformance against the S&P 500 in the long term.)


The current price of $94.25 does not indicate a dramatic surge or drop.  The combination of a slightly positive PPO, a negative relative divergence, and price below moving averages suggests cautious optimism; there's potential for a short-term rebound but a longer-term outlook hinges on broader market conditions and company performance.


**4. Recent Earnings and Outlook:**

The provided earnings data shows relatively stable revenue around $5 billion per quarter, with slight fluctuations. EPS has also remained relatively consistent.  There is no information on earnings expectations for comparison.  More detailed analysis requires access to earnings calls, analyst reports, and future guidance from Colgate-Palmolive.

| Date       | EPS | Revenue       |
|------------|-----|---------------|
| 2024-10-25 | 0.9 | $5.03 B       |
| 2024-07-26 | 0.89 | $5.06 B       |
| 2024-04-26 | 0.83 | $5.07 B       |
| 2023-10-27 | 0.86 | $4.92 B       |
| 2024-10-25 | 0.86 | $4.92 B       |


**6. Financial Information:**

The financial data reveals strong and consistent revenue and profit margins, although profit margin shows a slight downward trend.  However, Return on Equity (ROE) displays significant volatility. While high ROE figures can indicate efficiency, the negative ROE (-7866.67%) in one quarter is alarming and warrants further investigation.


**7. News and Recent Issues:**

*(This section requires real-time information gathering.  Please consult reputable financial news sources like Shacknews, FINBOLD, etc., for any news released within the last two days concerning Colgate-Palmolive's earnings, market outlook, analyst opinions, and performance highlights.)*


**8. Overall Analysis:**

Colgate-Palmolive has shown consistent revenue but has significantly underperformed the S&P 500 over the given period. While technical indicators are mixed, the price is below its moving averages, suggesting a possible bearish trend. High volatility in ROE raises concerns about financial stability.  Further investigation is needed into the outlier ROE quarter and recent news to determine a clearer picture.  The 0% expected return highlights a need for cautious optimism regarding long-term outperformance against the broader market.  Additional research, including analyst forecasts and company guidance, is crucial before making any investment decisions.


**9. Disclaimer:** This report is for informational purposes only and does not constitute financial advice.  The information provided is based on the limited data supplied and should not be the sole basis for investment decisions.  Always conduct thorough due diligence and consult with a qualified financial advisor before investing in any security.
